Changes in Rosuvastatin Pharmacokinetics During Postnatal Ontogenesis in Rats
Purpose: Statin therapy should be considered in children with familial hypercholesterolemia and sustained high LDL-C levels. There are no data on rosuvastatin exposure in patients <6 years and efficacy/safety can only be derived from case reports. Our aim was to examine developmental changes in p...
Saved in:
Main Authors: | Jaroslava Roušarová (Author), Martin Šíma (Author), Petr Kozlík (Author), Tomáš Křížek (Author), Ondřej Slanař (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacokinetic Variability in Pre-Clinical Studies: Sample Study with Abiraterone in Rats and Implications for Short-Term Comparative Pharmacokinetic Study Designs
by: Jana Královičová, et al.
Published: (2022) -
Ivacaftor pharmacokinetics and lymphatic transport after enteral administration in rats
by: Jiří Pozniak, et al.
Published: (2024) -
Development of immediate‐release formulation with reliable absorption of rivaroxaban in various meal regimes
by: Jan Bosák, et al.
Published: (2024) -
Factors Affecting the Metabolic Conversion of Ciprofloxacin and Exposure to Its Main Active Metabolites in Critically Ill Patients: Population Pharmacokinetic Analysis of Desethylene Ciprofloxacin
by: Martin Šíma, et al.
Published: (2022) -
What Is the Best Predictor of Phenobarbital Pharmacokinetics to Use for Initial Dosing in Neonates?
by: Martin Šíma, et al.
Published: (2021)